Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Tech Daily Nauru.
Press releases published on September 2, 2025
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025
GlobeNewswire
·
September 2, 2025
PITTSBURGH, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the Cantor Global Healthcare Conference 2025 on September 4, 2025, in New York. Krish S. Krishnan, …
First Set of 1-Year Clinical Results from RESOLVE Trial in Eosinophilic Esophagitis (EoE), Durable and Sustained Symptom & Tissue Responses after Dosing with EP-104GI
GlobeNewswire
·
September 2, 2025
At 12 months, 2/3rds of Cohort 5 patients (48mg dose, 4mg per site) remained in clinical remission after their treatment with EP-104GI All Cohorts followed to 9 months have maintained clinically meaningful improvements in tissue health as measured by EoE …
vTv Therapeutics Announces $80 Million Private Placement with Leading Healthcare Institutional Investors and the T1D Fund
GlobeNewswire
·
September 2, 2025
Proceeds to fund ongoing CATT1 Phase 3 trial and continued development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes Topline data from CATT1 Phase 3 trial on …
Pelthos Therapeutics to Participate in the 2025 Wells Fargo Healthcare Conference
GlobeNewswire
·
September 2, 2025
DURHAM, N.C., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today …
Replimune Announces Type A Meeting Scheduled with FDA
GlobeNewswire
·
September 2, 2025
WOBURN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that a Type A meeting with the U.S. Food and Drug …
CareCloud Increases 2025 Revenue Guidance Following Medsphere Acquisition
GlobeNewswire
·
September 2, 2025
Company Raises 2025 Revenue Outlook to $116 –$118 Million; Expects 2026 Revenue to be $128 –$130 Million SOMERSET, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare …
zSpace and The Glimpse Group Partner to Transform Healthcare Education with Virtual Medical Assisting Skills Training
GlobeNewswire
·
September 2, 2025
SAN JOSE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC), a leader in immersive augmented reality (AR) solutions for education, today announced a strategic partnership with The Glimpse Group, Inc., a spatial computing, AI and …
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire
·
September 2, 2025
ZUG, Switzerland and BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior …
Advent Technologies Moves Forward with €34.5 Million RHyno Project Funded by EU Innovation Fund
GlobeNewswire
·
September 2, 2025
ATHENS, Greece, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in the fuel cell and hydrogen technology space, announce today that its wholly owned Greek subsidiary, Advanced Energy …
ZenaTech’s Zena AI Launches a Quantum Computing Initiative for US Defense and Homeland Security Drone Applications
GlobeNewswire
·
September 2, 2025
VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), …
Rezolve Ai to Announce Strong First Half 2025 Results and Accelerated Growth Momentum
GlobeNewswire
·
September 2, 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the company reinventing retail through real-time AI-driven consumer engagement, today announced it will release its financial results for the first half of 2025 before market open on …
CEA Industries ($BNC) Expands Holdings to 388,888 BNB ($330M USD), Targets 1% Supply by Year-End
GlobeNewswire
·
September 2, 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq: BNC), (“BNC” or the “Company”), today announced the purchase of an additional 38,888 BNB ($33M USD) tokens, bringing its total holdings to 388,888 BNB ($330M USD) and further …
Genius Group and Nuanu sign $14 million Share Purchase & Joint Venture Agreement, launching Genius City, Bali
GlobeNewswire
·
September 2, 2025
SINGAPORE, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced the signing of a Share Purchase and Joint Venture Agreement …
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
CLEVELAND, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule …
BridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical Hypoparathyroidism
GlobeNewswire
·
September 2, 2025
PALO ALTO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that an oral presentation of Phase 2 data in …
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
GlobeNewswire
·
September 2, 2025
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress YAVNE, Israel, September 2, 2025 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue …
Rezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor Hyperinsulinism
GlobeNewswire
·
September 2, 2025
Open-label study in as few as 16 tumor hyperinsulinism (HI) patients Study initiated and enrolling patients in the U.S. and Europe Topline data expected in the second half of 2026 REDWOOD CITY, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. ( …
CorMedix Completes Acquisition of Melinta Therapeutics, Raises Financial Guidance and Announces New Leadership Team
GlobeNewswire
·
September 2, 2025
- Transformational deal for CorMedix that expands and diversifies company’s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potential - - Revised guidance of pro forma 2025 …
Digi Power X Expands Digital Asset Holdings and Accelerates Pivot to AI Infrastructure with Alabama Build-Out and Reports August 2025 Production Results
GlobeNewswire
·
September 2, 2025
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. MIAMI, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Digi Power X Inc. (“ …
Theratechnologies annonce que les agences de conseil en vote indépendantes ISS et Glass Lewis recommandent aux actionnaires de voter « EN FAVEUR » du plan d’arrangement prévu avec Future Pak
GlobeNewswire
·
September 2, 2025
Votre vote est important, quel que soit le nombre d’actions que vous détenez. Le conseil d’administration recommande à l’unanimité aux actionnaires de voter EN FAVEUR de l’arrangement. Les actionnaires sont invités à lire attentivement la circulaire et à …